HiberCell Competitors and Similar CompaniesClear all
Eisbach Bio's competitors and similar companies include PEP-Therapy and Odyssey Therapeutics.
 Eisbach Bio Eisbach Bio is a company that develops drugs to target molecular vulnerabilities arising in cancer genomes. |  PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. | |
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2021 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Planegg, DE HQ | Locations Paris, FR HQ Évry, FR | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US |
Employees | Employees 118% decrease | Employees 14 | Employees 1481% decrease |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 3m | Total funding raised $ 386m |
For sources of this data, please see the company profile
View Company Profiles
PEP-Therapy
HQ
Paris, FR
Employees
14
PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View company